These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 16751708)

  • 21. Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
    Di Carlo G; Izzo AA
    Expert Opin Investig Drugs; 2003 Jan; 12(1):39-49. PubMed ID: 12517253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoid system: An overview of its potential in current medical practice.
    Mouslech Z; Valla V
    Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids as gastrointestinal anti-inflammatory drugs.
    Fabisiak A; Fichna J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28239924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cannabis in digestive disorders.
    Goyal H; Singla U; Gupta U; May E
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):135-143. PubMed ID: 27792038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocannabinoid system: a drug discovery perspective.
    Piomelli D
    Curr Opin Investig Drugs; 2005 Jul; 6(7):672-9. PubMed ID: 16044662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF; Katona I; Piomelli D
    Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids as novel mediators of liver diseases.
    Mallat A; Lotersztajn S
    J Endocrinol Invest; 2006; 29(3 Suppl):58-65. PubMed ID: 16751709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocannabinoids in the central nervous system].
    Venance L; Maldonado R; Manzoni O
    Med Sci (Paris); 2004 Jan; 20(1):45-53. PubMed ID: 14770363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
    Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
    Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptors in atherosclerosis.
    Steffens S; Mach F
    Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.
    Darmani NA
    Methods Mol Med; 2006; 123():169-89. PubMed ID: 16506408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic modulation by endocannabinoids.
    Lovinger DM
    Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of the endogenous cannabinoid system in various neuropsychiatric disorders].
    Schneider U; Muller-Vahl KR; Stuhrmann M; Gadzicki D; Heller D; Seifert J; Emrich HM
    Fortschr Neurol Psychiatr; 2000 Oct; 68(10):433-8. PubMed ID: 11103679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobiology and systems physiology of the endocannabinoid system.
    Wegener N; Koch M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S79-86. PubMed ID: 19434559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The modulatory role of endocannabinoids in sleep].
    Murillo-Rodríguez E
    Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
    Blandizzi C
    Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
    Hasenoehrl C; Taschler U; Storr M; Schicho R
    Neurogastroenterol Motil; 2016 Dec; 28(12):1765-1780. PubMed ID: 27561826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.